RT @HenryMuney: Looking back at @JAMAOnc 2022, the acceptance rate of research articles was 8%. Publishing the #DCVax-L Phase 3 trial and r…
RT @HenryMuney: Looking back at @JAMAOnc 2022, the acceptance rate of research articles was 8%. Publishing the #DCVax-L Phase 3 trial and r…
RT @HenryMuney: Looking back at @JAMAOnc 2022, the acceptance rate of research articles was 8%. Publishing the #DCVax-L Phase 3 trial and r…
RT @HenryMuney: JAMA article is published and Dr. Linda Liau interview! $NWBO #DCVax-L 1. https://t.co/pfRDJSM1lP 2. https://t.co/O1rkNG8t…
RT @HenryMuney: Looking back at @JAMAOnc 2022, the acceptance rate of research articles was 8%. Publishing the #DCVax-L Phase 3 trial and r…
RT @HenryMuney: Looking back at @JAMAOnc 2022, the acceptance rate of research articles was 8%. Publishing the #DCVax-L Phase 3 trial and r…
RT @HenryMuney: Looking back at @JAMAOnc 2022, the acceptance rate of research articles was 8%. Publishing the #DCVax-L Phase 3 trial and r…
RT @HenryMuney: Looking back at @JAMAOnc 2022, the acceptance rate of research articles was 8%. Publishing the #DCVax-L Phase 3 trial and r…
RT @HenryMuney: Looking back at @JAMAOnc 2022, the acceptance rate of research articles was 8%. Publishing the #DCVax-L Phase 3 trial and r…
$NWBO
RT @HenryMuney: Looking back at @JAMAOnc 2022, the acceptance rate of research articles was 8%. Publishing the #DCVax-L Phase 3 trial and r…
RT @HenryMuney: Looking back at @JAMAOnc 2022, the acceptance rate of research articles was 8%. Publishing the #DCVax-L Phase 3 trial and r…
RT @HenryMuney: Looking back at @JAMAOnc 2022, the acceptance rate of research articles was 8%. Publishing the #DCVax-L Phase 3 trial and r…
RT @HenryMuney: Looking back at @JAMAOnc 2022, the acceptance rate of research articles was 8%. Publishing the #DCVax-L Phase 3 trial and r…
RT @HenryMuney: Looking back at @JAMAOnc 2022, the acceptance rate of research articles was 8%. Publishing the #DCVax-L Phase 3 trial and r…
RT @HenryMuney: Looking back at @JAMAOnc 2022, the acceptance rate of research articles was 8%. Publishing the #DCVax-L Phase 3 trial and r…
RT @HenryMuney: Looking back at @JAMAOnc 2022, the acceptance rate of research articles was 8%. Publishing the #DCVax-L Phase 3 trial and r…
Looking back at @JAMAOnc 2022, the acceptance rate of research articles was 8%. Publishing the #DCVax-L Phase 3 trial and results was quite the accomplishment. 1. https://t.co/kj90HJAi3f 2. https://t.co/pfRDJT4azX $NWBO https://t.co/3NLVBMakHp
RT @MonsonVO: @matthwilliams There is no debate. DCVAX is proven effective as presented on 10/05/22 NYAS presentation & the 70+ peer review…
@matthwilliams There is no debate. DCVAX is proven effective as presented on 10/05/22 NYAS presentation & the 70+ peer reviewed article published 17/11/22 by Journal of American Medical Association Oncology. #nwbo is on the brink of regulatory approval
RT @Arhdan9: @FDAOncology @POTUS re $NWBO for #cancermoonshot & All pompous or humble #hedgefund #managers #owners #politicians #influencer…
RT @Arhdan9: @FDAOncology @POTUS re $NWBO for #cancermoonshot & All pompous or humble #hedgefund #managers #owners #politicians #influencer…
RT @Arhdan9: @FDAOncology @POTUS re $NWBO for #cancermoonshot & All pompous or humble #hedgefund #managers #owners #politicians #influencer…
@FDAOncology @POTUS re $NWBO for #cancermoonshot & All pompous or humble #hedgefund #managers #owners #politicians #influencers & #themass LOOKING NO FURTHER THAN #OTC $NWBO FOR A SOLUTION TO END #CANCERS using #DCVax alone, particularly in #combin
RT @flaskworks: @GREEK__G0D @Keubiko Sorry that you're flat earther who doesn't believe in science. Many recognize $NWBO's groundbreaki…
RT @flaskworks: @GREEK__G0D @Keubiko Sorry that you're flat earther who doesn't believe in science. Many recognize $NWBO's groundbreaki…
RT @ATLnsider: Dr. Matt Williams wants to deprive UK nGBM & rGBM patients the right to use #DCVax-L even though $NWBO trial was a success &…
RT @ATLnsider: Dr. Matt Williams wants to deprive UK nGBM & rGBM patients the right to use #DCVax-L even though $NWBO trial was a success &…
RT @ATLnsider: Dr. Matt Williams wants to deprive UK nGBM & rGBM patients the right to use #DCVax-L even though $NWBO trial was a success &…
RT @flaskworks: Buy $NWBO Now Or Cry Later! https://t.co/m0FMWDAnBB https://t.co/UbQi4GbIF9 https://t.co/Dq9q51Eqow https://t.co/BvX1…
RT @flaskworks: Buy $NWBO Now Or Cry Later! https://t.co/m0FMWDAnBB https://t.co/UbQi4GbIF9 https://t.co/Dq9q51Eqow https://t.co/BvX1…
RT @flaskworks: @matthwilliams 73 authors in @JAMAOnc disagree with your claims regarding $NWBO's Landmark DCVax Trial. Many have called i…
RT @flaskworks: @matthwilliams 73 authors in @JAMAOnc disagree with your claims regarding $NWBO's Landmark DCVax Trial. Many have called i…
https://t.co/8pBvxeU7zZ $nwbo @alphavestcap
RT @flaskworks: Buy $NWBO Now Or Cry Later! https://t.co/m0FMWDAnBB https://t.co/UbQi4GbIF9 https://t.co/Dq9q51Eqow https://t.co/BvX1…
RT @flaskworks: Buy $NWBO Now Or Cry Later! https://t.co/m0FMWDAnBB https://t.co/UbQi4GbIF9 https://t.co/Dq9q51Eqow https://t.co/BvX1…
RT @flaskworks: Buy $NWBO Now Or Cry Later! https://t.co/m0FMWDAnBB https://t.co/UbQi4GbIF9 https://t.co/Dq9q51Eqow https://t.co/BvX1…
RT @flaskworks: Buy $NWBO Now Or Cry Later! https://t.co/m0FMWDAnBB https://t.co/UbQi4GbIF9 https://t.co/Dq9q51Eqow https://t.co/BvX1…
RT @flaskworks: Buy $NWBO Now Or Cry Later! https://t.co/m0FMWDAnBB https://t.co/UbQi4GbIF9 https://t.co/Dq9q51Eqow https://t.co/BvX1…
RT @flaskworks: Buy $NWBO Now Or Cry Later! https://t.co/m0FMWDAnBB https://t.co/UbQi4GbIF9 https://t.co/Dq9q51Eqow https://t.co/BvX1…
RT @flaskworks: Buy $NWBO Now Or Cry Later! https://t.co/m0FMWDAnBB https://t.co/UbQi4GbIF9 https://t.co/Dq9q51Eqow https://t.co/BvX1…
RT @Doc_Hieu: Oh snap! Bosch in the nicest way possible schooling Matt Williams.
RT @KauriCapital: @userofintellect @GaryGensler $NWBO is providing tailored cancer therapy & yet being naked shorted. 30-60% daily volume i…
RT @flaskworks: @SnackBioTech $NWBO has life-saving treatment for newly diagnosed and recurrent GBM. Breakthrough results! Attacks on @JA…
RT @KauriCapital: @userofintellect @GaryGensler $NWBO is providing tailored cancer therapy & yet being naked shorted. 30-60% daily volume i…
RT @flaskworks: @SnackBioTech $NWBO has life-saving treatment for newly diagnosed and recurrent GBM. Breakthrough results! Attacks on @JA…
RT @yachtmastter: #cancer #UK this!
RT @KauriCapital: @userofintellect @GaryGensler $NWBO is providing tailored cancer therapy & yet being naked shorted. 30-60% daily volume i…
RT @KauriCapital: @userofintellect @GaryGensler $NWBO is providing tailored cancer therapy & yet being naked shorted. 30-60% daily volume i…
RT @KauriCapital: @userofintellect @GaryGensler $NWBO is providing tailored cancer therapy & yet being naked shorted. 30-60% daily volume i…
RT @KauriCapital: @userofintellect @GaryGensler $NWBO is providing tailored cancer therapy & yet being naked shorted. 30-60% daily volume i…
@userofintellect @GaryGensler $NWBO is providing tailored cancer therapy & yet being naked shorted. 30-60% daily volume is short & Gary et al have done nothing https://t.co/qF3sCoXzIu https://t.co/Ji7W5ACPjJ
RT @yachtmastter: #cancer #UK this!
RT @hoffmann6383: @TommyBaxendale Scary that @matthwilliams is advising actual GBM patients when it appears he has trouble reading and unde…
RT @hoffmann6383: @TommyBaxendale Scary that @matthwilliams is advising actual GBM patients when it appears he has trouble reading and unde…
RT @hoffmann6383: @TommyBaxendale Scary that @matthwilliams is advising actual GBM patients when it appears he has trouble reading and unde…
RT @yachtmastter: #cancer #UK this!
RT @hoffmann6383: @TommyBaxendale Scary that @matthwilliams is advising actual GBM patients when it appears he has trouble reading and unde…
RT @hoffmann6383: @TommyBaxendale Scary that @matthwilliams is advising actual GBM patients when it appears he has trouble reading and unde…
RT @hoffmann6383: @TommyBaxendale Scary that @matthwilliams is advising actual GBM patients when it appears he has trouble reading and unde…
@TommyBaxendale Scary that @matthwilliams is advising actual GBM patients when it appears he has trouble reading and understanding a peer reviewed journal article related to GBM https://t.co/M53DdAw0kG $NWBO https://t.co/tGPI64HfTL
RT @flaskworks: Billions in revenue for $NWBO shareholders are imminent. Don't let the criminal spoofers or short selling social media tro…
RT @MonsonVO: @matthwilliams Glad to see you agree with 73 Neuro Oncologists that DC VAX OS is successful and will be approved shortly by R…
@matthwilliams Read author's response - Marnix Bosch, BS, MBA, PhD | Northwest Biotherapeutics, Inc Notice he declares his conflict of interests unlike you who hide yours whilst bashing other Doctor's life-saving work...Shame on you! https://t.co/kBdZtE4H7
@matthwilliams Glad to see you agree with 73 Neuro Oncologists that DC VAX OS is successful and will be approved shortly by RAs! https://t.co/2vKkJm7A8N Go #nwbo! #GBM #JAMA
RT @StaceyLClardy: Something new and promising in #Glioblastoma - have a listen @AANmember 👇🏼🧠🎙️@NeuroOnc
RT @flaskworks: Billions in revenue for $NWBO shareholders are imminent. Don't let the criminal spoofers or short selling social media tro…
RT @flaskworks: Billions in revenue for $NWBO shareholders are imminent. Don't let the criminal spoofers or short selling social media tro…
RT @flaskworks: Billions in revenue for $NWBO shareholders are imminent. Don't let the criminal spoofers or short selling social media tro…
@matthwilliams Care to comment?
RT @flaskworks: Billions in revenue for $NWBO shareholders are imminent. Don't let the criminal spoofers or short selling social media tro…
RT @flaskworks: Billions in revenue for $NWBO shareholders are imminent. Don't let the criminal spoofers or short selling social media tro…
RT @flaskworks: Billions in revenue for $NWBO shareholders are imminent. Don't let the criminal spoofers or short selling social media tro…
RT @justinkeister5: Dr Bosch’s response on behalf of the authors to JAMA article criticisms are a thoughtful rebuke of the omissions and mi…
RT @HenryMuney: $NWBO CTO Marnix Bosch responded on April 11, 2023 to comments to the @JAMAOnc article on the #DCVax-L Phase 3 trial. http…
RT @HassanClan: $NWBO Train is coming ... Don't Waiver in the onslaught of FUD spreaders and price manipulation #Dcvax https://t.co/9GCmZyK…
RT @justinkeister5: Dr Bosch’s response on behalf of the authors to JAMA article criticisms are a thoughtful rebuke of the omissions and mi…
RT @Arhdan9: $NWBO $XBI #CitadelScandal No #billionaire #billionairemindset want to play with & win over #DCVax cancer vaccine killer corr…
$NWBO $XBI #CitadelScandal No #billionaire #billionairemindset want to play with & win over #DCVax cancer vaccine killer corrupted @Citadel Ken Griffin. LOL, what a twisted world. https://t.co/aztg3lSg99 https://t.co/Ji6ltP29NJ
RT @ATLnsider: Dr. Matt Williams wants to deprive UK nGBM & rGBM patients the right to use #DCVax-L even though $NWBO trial was a success &…
RT @HenryMuney: $NWBO CTO Marnix Bosch responded on April 11, 2023 to comments to the @JAMAOnc article on the #DCVax-L Phase 3 trial. http…
RT @HassanClan: $NWBO Train is coming ... Don't Waiver in the onslaught of FUD spreaders and price manipulation #Dcvax https://t.co/9GCmZyK…
RT @ATLnsider: Dr. Matt Williams wants to deprive UK nGBM & rGBM patients the right to use #DCVax-L even though $NWBO trial was a success &…
RT @ATLnsider: Dr. Matt Williams wants to deprive UK nGBM & rGBM patients the right to use #DCVax-L even though $NWBO trial was a success &…
RT @HenryMuney: $NWBO CTO Marnix Bosch responded on April 11, 2023 to comments to the @JAMAOnc article on the #DCVax-L Phase 3 trial. http…
RT @ATLnsider: Dr. Matt Williams wants to deprive UK nGBM & rGBM patients the right to use #DCVax-L even though $NWBO trial was a success &…
RT @HenryMuney: $NWBO CTO Marnix Bosch responded on April 11, 2023 to comments to the @JAMAOnc article on the #DCVax-L Phase 3 trial. http…
RT @Doc_Hieu: Oh snap! Bosch in the nicest way possible schooling Matt Williams.
RT @HenryMuney: $NWBO CTO Marnix Bosch responded on April 11, 2023 to comments to the @JAMAOnc article on the #DCVax-L Phase 3 trial. http…
RT @HenryMuney: JAMA article is published and Dr. Linda Liau interview! $NWBO #DCVax-L 1. https://t.co/pfRDJSM1lP 2. https://t.co/O1rkNG8t…
RT @ATLnsider: Dr. Matt Williams wants to deprive UK nGBM & rGBM patients the right to use #DCVax-L even though $NWBO trial was a success &…
RT @justinkeister5: Dr Bosch’s response on behalf of the authors to JAMA article criticisms are a thoughtful rebuke of the omissions and mi…
RT @HenryMuney: $NWBO CTO Marnix Bosch responded on April 11, 2023 to comments to the @JAMAOnc article on the #DCVax-L Phase 3 trial. http…
RT @HenryMuney: $NWBO CTO Marnix Bosch responded on April 11, 2023 to comments to the @JAMAOnc article on the #DCVax-L Phase 3 trial. http…
RT @ATLnsider: Dr. Matt Williams wants to deprive UK nGBM & rGBM patients the right to use #DCVax-L even though $NWBO trial was a success &…